Elevance Health, Inc. (NYSE:ELV – Free Report) – Investment analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of Elevance Health in a research report issued on Wednesday, April 23rd. Cantor Fitzgerald analyst S. James now forecasts that the company will post earnings per share of $34.47 for the year, down from their previous forecast of $34.57. Cantor Fitzgerald has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $33.96 per share.
Elevance Health (NYSE:ELV – Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The company reported $11.97 earnings per share for the quarter, topping the consensus estimate of $10.60 by $1.37. The business had revenue of $48.77 billion during the quarter, compared to analysts’ expectations of $46.26 billion. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%.
View Our Latest Stock Analysis on ELV
Elevance Health Stock Up 0.5 %
Shares of ELV stock opened at $429.08 on Thursday. Elevance Health has a 12 month low of $362.21 and a 12 month high of $567.26. The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.71. The firm has a market cap of $97.14 billion, a PE ratio of 16.75, a price-to-earnings-growth ratio of 1.18 and a beta of 0.77. The stock has a 50 day moving average of $419.22 and a 200-day moving average of $408.94.
Institutional Trading of Elevance Health
Hedge funds have recently modified their holdings of the stock. Virtu Financial LLC acquired a new stake in shares of Elevance Health in the 3rd quarter valued at $2,828,000. Te Ahumairangi Investment Management Ltd increased its position in Elevance Health by 39.6% in the third quarter. Te Ahumairangi Investment Management Ltd now owns 10,508 shares of the company’s stock worth $5,433,000 after purchasing an additional 2,983 shares during the period. Tudor Financial Inc. bought a new stake in Elevance Health during the 3rd quarter worth about $235,000. Anchor Investment Management LLC lifted its position in Elevance Health by 22.9% during the 3rd quarter. Anchor Investment Management LLC now owns 6,098 shares of the company’s stock valued at $3,171,000 after purchasing an additional 1,135 shares during the period. Finally, World Investment Advisors LLC bought a new position in shares of Elevance Health in the 3rd quarter valued at about $8,855,000. 89.24% of the stock is owned by institutional investors.
Insider Buying and Selling at Elevance Health
In related news, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the company’s stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $396.30, for a total transaction of $1,388,635.20. Following the transaction, the executive vice president now owns 10,116 shares in the company, valued at $4,008,970.80. This represents a 25.73 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ronald W. Penczek sold 443 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $415.13, for a total transaction of $183,902.59. Following the completion of the sale, the chief accounting officer now owns 1,847 shares of the company’s stock, valued at $766,745.11. The trade was a 19.34 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.29% of the company’s stock.
Elevance Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Tuesday, June 10th will be issued a dividend of $1.71 per share. This represents a $6.84 annualized dividend and a yield of 1.59%. The ex-dividend date is Tuesday, June 10th. Elevance Health’s dividend payout ratio is currently 26.71%.
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
See Also
- Five stocks we like better than Elevance Health
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- How to Use Stock Screeners to Find Stocks
- Why Smart Investors Don’t Panic in Election Season
- Why Invest in 5G? How to Invest in 5G Stocks
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.